1 / 7

Extracorporeal Membrane Oxygenation Market Future Challenges by 2032

Global Market Insights Inc. adds Global Extracorporeal Membrane Oxygenation Market Report focuses on the major drivers and restraints for the Global key players. It also provides analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.

energy010
Download Presentation

Extracorporeal Membrane Oxygenation Market Future Challenges by 2032

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Extracorporeal Membrane Oxygenation Market Research Report Analysis and Forecasts to 2032

  2. Industry Insights • The prevalence of respiratory and cardiovascular illnesses has increased dramatically throughout the European region in recent years, and this trend is expected to continue over the forecast time. • An increase in CVD cases has led to introduction of government measures and implementation of different programs in the area to raise public awareness. • Government funding for infrastructure development in emerging nations would help make expensive machines more accessible, which will boost industry revenue growth. • For instance, in January 2021, BraileBiomedica, in collaboration with the Eldorado Institute and Embrapii, introduced the SOLIS System, a nationwide product against COVID-19. • Extracorporeal membrane oxygenation (ECMO), a type of extracorporeal breathing, makes up the system. The corporation has benefited from such product introductions in securing its market position.

  3. Based on approach, the veno-venous (VV) segment held more than $180 million in 2022. The veno-venous ECMO device increases blood flow and oxygen levels while reducing cardiac effort and supporting hemodynamics. • There will likely be a rise in demand for veno-venous ECMO through the forecast years due to the growing burden of cardiopulmonary diseases. • With respect to type, the respiratory segment is poised to grow at more than 3% CAGR from 2023 to 2032. A significant factor in the segment's growth is the risk of respiratory failure among individuals with different respiratory illnesses. • Besides, the expanding geriatric population that is vulnerable to respiratory ailments, would further complement the growing market landscape.

  4. Regional Analysis • From the regional front, the Latin America extracorporeal membrane oxygenation (ECMO) market is estimated to grow at more than 4% CAGR from 2023 to 2032. The expansion is fueled by the burgeoning use of cutting-edge ECMO technology in healthcare settings in LATAM nations along with the region's rising respiratory and cardiac disease rates. • Competitive Analysis • The global extracorporeal membrane oxygenation market consists of several players including Abbott Laboratories, Fresenius Medical Care AG & Co. KGaA, BraileBiomedica, Edwards Lifesciences Corporation, Abiomed, Eurosets, Getinge AB, LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Nipro, SB-Kawasumi Laboratories, Inc., Spectrum Medical, and Terumo Corporation, among others.

  5. Extracorporeal Membrane Oxygenation Market @ https://www.gminsights.com/industry-analysis/extracorporeal-membrane-oxygenation-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/2720 Request for customization @ https://www.gminsights.com/roc/2720

  6. Stay In Touch Social Media:

  7. THANK YOU www.gminsights.com

More Related